Waddell & Associates’s West Pharmaceutical WST Stock Holding History

Waddell & Associates’s Portfolio WST Stock Details WST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$736K	Hold	2,049	–	–	0.04%	179
2026 Q1	$514K	Sell	2,049 -1,573	-43%	-$391K	0.03%	232
2025 Q4	$997K	Buy	3,622 +112	+3%	+$30.6K	0.07%	91
2025 Q3	$921K	Buy	3,510 +598	+21%	+$145K	0.08%	75
2025 Q2	$637K	Buy	2,912 +12	+0.4%	+$2.56K	0.07%	83
2025 Q1	$649K	Sell	2,900 -1,000	-26%	-$276K	0.08%	68
2024 Q4	$1.28M	Hold	3,900	–	–	0.13%	43
2024 Q3	$1.17M	Hold	3,900	–	–	0.14%	44
2024 Q2	$1.28M	Hold	3,900	–	–	0.17%	42
2024 Q1	$1.54M	Hold	3,900	–	–	0.21%	38
2023 Q4	$1.37M	Hold	3,900	–	–	0.18%	42
2023 Q3	$1.46M	Hold	3,900	–	–	0.21%	41
2023 Q2	$1.49M	Hold	3,900	–	–	0.22%	41
2023 Q1	$1.35M	Hold	3,900	–	–	0.21%	41
2022 Q4	$918K	Hold	3,900	–	–	0.15%	46
2022 Q3	$960K	Hold	3,900	–	–	0.19%	43
2022 Q2	$1.18M	Hold	3,900	–	–	0.24%	34
2022 Q1	$1.6M	Hold	3,900	–	–	0.26%	30
2021 Q4	$1.83M	Hold	3,900	–	–	0.29%	23
2021 Q3	$1.66M	Hold	3,900	–	–	0.28%	23
2021 Q2	$1.4M	Buy	+3,900	New	+$1.29M	0.21%	23

Other funds holding WST

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

GIM

Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Waddell & Associates's WST Position: Q2 2026 in Review

Waddell & Associates held its West Pharmaceutical (WST) position steady in Q2 2026 at 2,049 shares worth $736K. The position accounts for 0.04% of the portfolio, ranked #179.

Waddell & Associates first reported a position in WST in Q2 2021 and has held it in 21 quarters since. The position peaked at $1.83M in Q4 2021. 831 funds tracked by Wall St. Rank hold WST as of Q2 2026.

Waddell & Associates held 2,049 shares of West Pharmaceutical worth $736K as of Q2 2026.
Waddell & Associates left its West Pharmaceutical share count unchanged in Q2 2026.
West Pharmaceutical made up 0.04% of Waddell & Associates's portfolio in Q2 2026, its #179 holding.
Waddell & Associates first reported a position in West Pharmaceutical in Q2 2021 and has held it in 21 quarters since.
Waddell & Associates's West Pharmaceutical position peaked at $1.83M in Q4 2021.
831 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Waddell & Associates's 13F filing for Q2 2026, filed 15 Jul 2026.